Urology
Volume 64, Issue 5 , Pages 871-875 , November 2004

Botulinum toxin a has antinociceptive effects in treating interstitial cystitis

  • Christopher P. Smith

      Affiliations

    • Scott Department of Urology, Baylor College of Medicine, Houston, Texas
    • C. P. Smith, P. Radziszewski, and M. B. Chancellor are paid consultants to Allergan, Inc., the manufacturer of a product mentioned in this article.
    • ,
  • Piotr Radziszewski

      Affiliations

    • Department of Urology, Warsaw School of Medicine, Warsaw, Poland
    • C. P. Smith, P. Radziszewski, and M. B. Chancellor are paid consultants to Allergan, Inc., the manufacturer of a product mentioned in this article.
    • ,
  • Andrzej Borkowski

      Affiliations

    • Department of Urology, Warsaw School of Medicine, Warsaw, Poland
    • ,
  • George T. Somogyi

      Affiliations

    • Scott Department of Urology, Baylor College of Medicine, Houston, Texas
    • ,
  • Timothy B. Boone

      Affiliations

    • Scott Department of Urology, Baylor College of Medicine, Houston, Texas
    • ,
  • Michael B. Chancellor

      Affiliations

    • Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Corresponding Author InformationReprint requests: Michael B. Chancellor, M.D., Departments of Urology and Obstetrics and Gynecology, University of Pittsburgh School of Medicine, 700 LS Kaufmann Building, 3471 Fifth Avenue, Pittsburgh, PA 15213
    • C. P. Smith, P. Radziszewski, and M. B. Chancellor are paid consultants to Allergan, Inc., the manufacturer of a product mentioned in this article.

Received 7 April 2004 ,Accepted 15 June 2004.

References 

  1. Jones CA , Harris MA , Nyberg L . Prevalence of interstitial cystitis in the United States . J Urol . 1994;151:138A; (abstract)
  2. Steers WD , Tuttle JB . Neurogenic inflammation and nerve growth factor (possible roles in interstitial cystitis) . In:  Sant GR editors. Interstitial Cystitis . Philadelphia: Lippincott-Raven; 1997;p. 67–75
  3. Cui M , Khanijou S , Rubino J , et al.   Subcutaneous administration of botulinum toxin A reduces formalin-induced pain . Pain . 2004;107:125–133
  4. Niku SD , Stein PC , Scherz HC , et al.   A new method for cytodestruction of bladder epithelium using protamine sulfate and urea . J Urol . 1994;152:1025–1028
  5. O’Leary MP , Sant GR , Fowler FJ , et al.   The Interstitial Cystitis Symptom Index and Problem Index . Urology . 1997;49(5A suppl):58–63
  6. Smith CP , Chancellor MB . Emerging role of botulinum toxin in the treatment of voiding dysfunction . J Urol . 2004;171(6, Pt 1 of 2):2128–2137
  7. Tsui JK , Eisen A , Stoessl AJ , et al.   Double-blind study of botulinum toxin in spasmodic torticollis . Lancet . 1986;2:245–247
  8. Cheshire WP , Abashian SW , Mann JD . Botulinum toxin in the treatment of myofascial pain syndrome . Pain . 1994;59:65–69
  9. Silberstein S , Mathew N , Saper J , et al.  BOTOX Migraine Clinical Research Group   Botulinum toxin type A as a migraine preventive treatment . Headache . 2000;40:445–450
  10. Jabbari B , Maher N , Difasio MP . Botulinum toxin improved burning pain and allodynia in two patients with spinal cord pathology . Pain Med . 2003;4:206–210
  11. Maria G , Destito A , Lacquaniti S , et al.   Relief by botulinum toxin of voiding dysfunction due to prostatitis . Lancet . 1998;352:625; (letter)
  12. Zermann D , Ishigooka M , Schubert J , et al.   Perisphincteric injection of botulinum toxin type A (a treatment option for patients with chronic prostatic pain?) . Eur Urol . 2000;38:393–399
  13. Welch MJ , Purkiss JR , Foster KA . Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins . Toxicon . 2000;38:245–258
  14. Maggi CA . The dual function of capsaicin-sensitive sensory nerves in the bladder and urethra . Ciba Found Symp . 1990;151:77–83
  15. Wakabayashi Y , Kojima Y , Makiura Y , et al.   Acetylcholinesterase positive axons in the mucosa of urinary bladder of adult cats (retrograde tracing and degeneration studies) . Histol Histopathol . 1995;10:523–530
  16. Andersson KE , Yoshida M . Antimuscarinics and the overactive detrusor—which is the main mechanism of action . Eur Urol . 2003;43:1–5
  17. Kim Y , Yoshimura N , Kwon DD , et al.   New mechanism of action of intravesical antimuscarinic agents . J Urol . 2004;171(suppl):327–328
  18. Fry CH , Ikeda Y , Harvey R , et al.   Control of bladder function by peripheral nerves (avenues for novel drug targets) . Urology . 2004;63(3 suppl 1):24–31
  19. Ferguson DR , Kennedy I , Burton TJ . ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes—a possible sensory mechanism? . J Physiol . 1997;505(Pt 2):503–511
  20. Sun Y , Chai TC . Extracellular adenosine triphosphate (ATP) stimulates more ATP release from interstitial cystitis bladder urothelial cells compared to control cells (abstract) . J Urol . 2004;171(4 suppl):97
  21. Sun Y , Keay S , De Deyne PG , et al.   Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis . J Urol . 2001;166:1951–1956
  22. Vlaskovska M , Kasakov L , Rong W , et al.   P2X3 knock-out mice reveal a major sensory role for urothelially released ATP . J Neurosci . 2001;21:5670–5677
  23. Black PH . Stress and the inflammatory response (a review of neurogenic inflammation) . Brain Behav Immun . 2002;16:622–653
  24. Sun Y , MaLossi J , Jacobs SC , et al.   Effect of doxazosin on stretch-activated adenosine triphosphate release in bladder urothelial cells from patients with benign prostatic hyperplasia . Urology . 2002;60:351–356
  25. Stein PC , Torri A , Parsons CL . Elevated urinary norepinephrine in interstitial cystitis . Urology . 1999;53:1140–1143
  26. Peeker R , Aldenborg F , Dahlstrom A , et al.   Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and nonulcer interstitial cystitis . J Urol . 2000;163:1112–1115
  27. Smith CP , Franks ME , McNeil BK , et al.   Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract . J Urol . 2003;169:1896–1900
  28. Vemulakonda VM , Smith CP , Kiss S , et al.   Botulinum toxin A inhibits mechanoreceptor-mediated urothelial release of ATP in conditions of bladder inflammation (abstract) . J Urol . 2004;171(4 suppl):95
  29. Vemulakonda VM , Somogyi GT , Kiss S , et al.   Intravesical botulinum toxin A inhibits the afferent response in the chronically inflamed bladder (abstract) . J Urol . 2004;171(4 suppl):458
  30. Sant GR , Propert KJ , Hanno PM , et al.   A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis . J Urol . 2003;170:810–815

 This study was supported by the Scott Department of Urology, Neurourology Fund, and the Fishbein Family CURE-IC (the funding sources had no involvement in the study method or data collection, analysis, or interpretation).

PII: S0090-4295(04)00952-5

doi: 10.1016/j.urology.2004.06.073

Urology
Volume 64, Issue 5 , Pages 871-875 , November 2004

Article Tools

* Image Usage & Resolution